These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 30909832)
1. Single dose oral ranolazine pharmacokinetics in patients receiving maintenance hemodialysis. Scoville BA; Segal JH; Salama NN; Heung M; Bleske BE; Eyler RF; Mueller BA Ren Fail; 2019 Nov; 41(1):118-125. PubMed ID: 30909832 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic drug-drug interaction study of ranolazine and metformin in subjects with type 2 diabetes mellitus. Zack J; Berg J; Juan A; Pannacciulli N; Allard M; Gottwald M; Zhang H; Shao Y; Ben-Yehuda O; Jochelson P Clin Pharmacol Drug Dev; 2015 Mar; 4(2):121-9. PubMed ID: 27128216 [TBL] [Abstract][Full Text] [Related]
3. Dose-finding study of rivaroxaban in hemodialysis patients. De Vriese AS; Caluwé R; Bailleul E; De Bacquer D; Borrey D; Van Vlem B; Vandecasteele SJ; Emmerechts J Am J Kidney Dis; 2015 Jul; 66(1):91-8. PubMed ID: 25804678 [TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics of irbesartan in renal failure and maintenance hemodialysis. Sica DA; Marino MR; Hammett JL; Ferreira I; Gehr TW; Ford NF Clin Pharmacol Ther; 1997 Dec; 62(6):610-8. PubMed ID: 9433389 [TBL] [Abstract][Full Text] [Related]
5. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions. Chen C; Bujanover S; Kareht S; Rapoport AM Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369 [TBL] [Abstract][Full Text] [Related]
6. Single-dose linezolid pharmacokinetics in critically ill patients with impaired renal function especially chronic hemodialysis patients. El-Assal MI; Helmy SA Biopharm Drug Dispos; 2014 Oct; 35(7):405-16. PubMed ID: 25044219 [TBL] [Abstract][Full Text] [Related]
7. Ranolazine (Roche Bioscience). Jones R IDrugs; 1999 Dec; 2(12):1353-62. PubMed ID: 16113967 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological Management of Chronic Stable Angina: Focus on Ranolazine. Rosano GMC; Vitale C; Volterrani M Cardiovasc Drugs Ther; 2016 Aug; 30(4):393-398. PubMed ID: 27417323 [TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study. Lal R; Sukbuntherng J; Luo W; Chen D; Blumenthal R; Ho J; Cundy KC Clin Ther; 2012 Jan; 34(1):201-13. PubMed ID: 22206794 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of a transdermal testosterone system in men with end stage renal disease receiving maintenance hemodialysis and healthy hypogonadal men. Singh AB; Norris K; Modi N; Sinha-Hikim I; Shen R; Davidson T; Bhasin S J Clin Endocrinol Metab; 2001 Jun; 86(6):2437-45. PubMed ID: 11397836 [TBL] [Abstract][Full Text] [Related]
11. Ranolazine: A Contemporary Review. Rayner-Hartley E; Sedlak T J Am Heart Assoc; 2016 Mar; 5(3):e003196. PubMed ID: 26979079 [No Abstract] [Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease. Smith WB; Dowell JA; Pratt RD Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis. Parasrampuria DA; Marbury T; Matsushima N; Chen S; Wickremasingha PK; He L; Dishy V; Brown KS Thromb Haemost; 2015 Apr; 113(4):719-27. PubMed ID: 25566930 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis. Wang X; Tirucherai G; Marbury TC; Wang J; Chang M; Zhang D; Song Y; Pursley J; Boyd RA; Frost C J Clin Pharmacol; 2016 May; 56(5):628-36. PubMed ID: 26331581 [TBL] [Abstract][Full Text] [Related]
15. Glucose-Lowering Medications and Angina Burden in Patients with Stable Coronary Disease: results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA) Trial. Arnold SV; McGuire DK; Spertus JA; Tang F; Yue P; Inzucchi SE; Belardinelli L; Chaitman BR; Kosiborod M Am Heart J; 2015 Oct; 170(4):753-759.e2. PubMed ID: 26386799 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and Safety of Extended-release Ranolazine in Korean and White Healthy Subjects. Yoo H; Lee SW; Yoon DY; Yoon SH; Cho JY; Yu KS; Jang IJ; Lee S Clin Ther; 2021 Mar; 43(3):526-534.e4. PubMed ID: 33518355 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and Dialyzability of a Single Oral Dose of Amenamevir, an Anti-Herpes Drug, in Hemodialysis Patients. Tsuruoka S; Endo T; Seo M; Hashimoto N Adv Ther; 2020 Jul; 37(7):3234-3245. PubMed ID: 32440976 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Rivaroxaban in Chronic Hemodialysis. Dias C; Moore KT; Murphy J; Ariyawansa J; Smith W; Mills RM; Weir MR Am J Nephrol; 2016; 43(4):229-36. PubMed ID: 27100875 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis. Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427 [TBL] [Abstract][Full Text] [Related]
20. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. Ifudu O; Feldman J; Friedman EA N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]